- Home
- UDMY vs AVDL Comparison
UDMY vs AVDL Comparison
Compare UDMY & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- AVDL
- Stock Information
- Founded
- UDMY 2009
- AVDL 2015
- Country
- UDMY United States
- AVDL Ireland
- Employees
- UDMY N/A
- AVDL N/A
- Industry
- UDMY Other Consumer Services
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- UDMY Real Estate
- AVDL Health Care
- Exchange
- UDMY Nasdaq
- AVDL Nasdaq
- Market Cap
- UDMY 1.2B
- AVDL 786.3M
- IPO Year
- UDMY 2021
- AVDL 1996
- Fundamental
- Price
- UDMY $7.48
- AVDL $7.84
- Analyst Decision
- UDMY Buy
- AVDL Strong Buy
- Analyst Count
- UDMY 10
- AVDL 6
- Target Price
- UDMY $10.95
- AVDL $20.00
- AVG Volume (30 Days)
- UDMY 621.9K
- AVDL 1.5M
- Earning Date
- UDMY 02-12-2025
- AVDL 03-03-2025
- Dividend Yield
- UDMY N/A
- AVDL N/A
- EPS Growth
- UDMY N/A
- AVDL N/A
- EPS
- UDMY N/A
- AVDL N/A
- Revenue
- UDMY $776,168,000.00
- AVDL $138,160,000.00
- Revenue This Year
- UDMY $9.33
- AVDL $515.63
- Revenue Next Year
- UDMY $3.30
- AVDL $49.32
- P/E Ratio
- UDMY N/A
- AVDL N/A
- Revenue Growth
- UDMY 10.14
- AVDL 1523.50
- 52 Week Low
- UDMY $6.67
- AVDL $7.39
- 52 Week High
- UDMY $14.74
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- UDMY 38.88
- AVDL 31.18
- Support Level
- UDMY $7.48
- AVDL $7.63
- Resistance Level
- UDMY $8.71
- AVDL $8.74
- Average True Range (ATR)
- UDMY 0.27
- AVDL 0.47
- MACD
- UDMY -0.06
- AVDL -0.17
- Stochastic Oscillator
- UDMY 22.43
- AVDL 14.29
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The Company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.